Viewing nowAllstatin 5 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.

MFDS item code 201402893 · Approved 2014.06.30 · Insurance code 651904020
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is used as an adjunct when dietary management and exercise are insufficient to control primary hypercholesterolemia and mixed dyslipidemia patients. It is also used with diet or other lipid-lowering therapies for patients with homozygous familial hypercholesterolemia. It helps lower total cholesterol and LDL cholesterol levels, thus delaying the progression of atherosclerosis. It serves as an adjunct therapy in children aged 10 to 17 years with heterozygous familial hypercholesterolemia who meet certain criteria. Additionally, it is used to support dietary management in patients with primary dysbetalipoproteinemia. Furthermore, it aids in reducing the risk of stroke, myocardial infarction, and revascularization in patients with certain age and cardiovascular risk factors. Thus, this drug is effectively used for various dyslipidemias and reducing cardiovascular disease risks.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased up to a maximum of 20 milligrams once daily. 3. Elderly: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40 milligrams dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40 milligrams dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. Dosage adjustments should be made at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.
This medication should not be used in individuals with certain allergic reactions or severe liver dysfunction. Those with muscle issues or taking certain medications, and individuals with severe renal impairment should also avoid this medication. Pregnant or breastfeeding women, as well as women who may become pregnant, must consult a physician before taking this medication and use appropriate contraceptive methods. Since this medication may cause muscle-related side effects, patients should immediately inform healthcare providers if symptoms such as myalgia or muscle weakness occur. Regular liver function tests and blood glucose monitoring are necessary as side effects may include liver dysfunction or elevated blood sugar. Individuals who consume alcohol excessively or have a history of liver disease should exercise caution when taking this medication and undergo frequent liver enzyme tests. This medication can increase drug concentration and risk of side effects when taken with certain other medications, so patients must inform their healthcare provider about any concurrent medications. Special precautions are necessary for children and adolescents, and their growth and development should be monitored regularly. Patients should be cautious when driving or operating machinery as dizziness may occur. In cases of overdose, as there are no specific antidotes, the patient should immediately visit a hospital for appropriate treatment. If severe rashes or allergic reactions occur during the course of this medication, the use should be immediately discontinued, and healthcare providers should be consulted.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, peripheral neuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distention, syncope, generalized pain
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to store it at room temperature, between 1 to 30 degrees Celsius.
Yellow round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Daiwoo Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Myungjin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Teragen Itex Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.